Insulin glargine compared to NPH among insulin-naïve, U.S. inner city, ethnic minority type 2 diabetic patients
- 31 March 2011
- journal article
- research article
- Published by Elsevier BV in Diabetes Research and Clinical Practice
- Vol. 91 (3), 293-299
- https://doi.org/10.1016/j.diabres.2010.11.028
Abstract
No abstract availableKeywords
Funding Information
- U.S. National Institutes of Health, NIDDK (DK54047)
- NCRR (RR14616)
This publication has 22 references indexed in Scilit:
- Direct costs associated with initiating NPH insulin versus glargine in patients with type 2 diabetes: A retrospective database analysisDiabetes Research and Clinical Practice, 2010
- The Treat-to-Target TrialDiabetes Care, 2003
- Safety and efficacy of insulin glargine (HOE 901) versus NPH insulin in combination with oral treatment in Type 2 diabetic patientsDiabetic Medicine, 2003
- Glimepiride Combined with Morning Insulin Glargine, Bedtime Neutral Protamine Hagedorn Insulin, or Bedtime Insulin Glargine in Patients with Type 2 DiabetesAnnals of Internal Medicine, 2003
- A One-year, Randomised, Multicentre Trial Comparing Insulin Glargine with NPH Insulin in Combination with Oral Agents in Patients with Type 2 DiabetesHormone and Metabolic Research, 2003
- Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.Diabetes Care, 2000
- Economic Determinants and Dietary Consequences of Food Insecurity in the United StatesJournal of Nutrition, 1999
- Hunger in an adult patient population.Jama-Journal Of The American Medical Association, 1998
- Food insufficiency exists in the United States: results from the third National Health and Nutrition Examination Survey (NHANES III).American Journal of Public Health, 1998
- Nutrient intakes of individuals from food-insufficient households in the United States.American Journal of Public Health, 1997